Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,756.76
(
2.11%
)
US TECH 100
24,176.80
(
2.69%
)
Dow Jones
47,674.47
(
2.34%
)
Brent Oil
93.07
(
-8.05%
)
Bitcoin
70,891.30
(
-1.52%
)
News Focus
News Focus
Post# of 30500
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 15
Posts 4014
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: DewDiligence post# 30169

Thursday, 08/21/2025 3:14:50 PM

Thursday, August 21, 2025 3:14:50 PM

Post# of 30500
VKTX- comparing phase 1 data from corporate deck shows 58% nausea/vomiting in placebo group vs 58% in phase 2 update. Same number but discontinuations higher. Less patience amongst cohorts to get over the early weeks rather than face saving IMO if I am reading the AE data correctly.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today